To highlight novel techniques and strategies in the management of colorectal cancer (CRC), addressing challenges in treatment and emphasizing the need for continuous innovation.
Key Findings:
Intraoperative IPC shows promise in reducing peritoneal metastasis risk.
CRS + HIPEC can improve survival but requires careful patient selection.
Targeted therapies can enhance local control in pulmonary oligometastases.
Machine learning can effectively predict liver metastasis risk from blood test indicators.
Interpretation:
The integration of innovative surgical techniques, targeted therapies, and advanced predictive models reflects a multidisciplinary approach to improving CRC management and patient outcomes.
Limitations:
Preliminary nature of some studies necessitates further validation.
High morbidity associated with aggressive treatments like CRS + HIPEC.
Conclusion:
The dynamic landscape of CRC treatment is evolving through the integration of novel strategies, emphasizing the need for personalized multimodal approaches to enhance survival and quality of life.
